Targeting the bacterial SOS response for new antimicrobial agents: drug targets, molecular mechanisms and inhibitors

Targeting the bacterial SOS response for new antimicrobial agents: drug targets, molecular mechanisms and inhibitors

Antimicrobial resistance is a pressing threat to global health, with multidrug-resistant pathogens becoming increasingly prevalent. The bacterial SOS pathway functions in response to DNA damage that occurs during infection, initiating several pro-survival and resistance mechanisms, such as DNA repai...

Szczegółowa specyfikacja

Opis bibliograficzny
1. autor:	Lanyon-Hogg, T
Format:	Journal article
Język:	English
Wydane:	Future Science 2021

Podobne zapisy

Staphylococcus aureus SOS response: Activation, impact, and drug targets
od: Kaiying Cheng, i wsp.
Wydane: (2024-09-01)

Development of an inhibitor of the mutagenic SOS response that suppresses the evolution of quinolone antibiotic resistance
od: Bradbury, JD, i wsp.
Wydane: (2024)

Role of Extracellular DNA in Bacterial Response to SOS-Inducing Drugs
od: John K. Crane, i wsp.
Wydane: (2023-03-01)

Targeting evolution of antibiotic resistance by SOS response inhibition
od: Alexander Yakimov, i wsp.
Wydane: (2021-01-01)

Sending out an SOS - the bacterial DNA damage response
od: Marco A. Lima-Noronha, i wsp.
Wydane: (2022-10-01)

Novel Targets and Mechanisms in Antimicrobial Drug Discovery
od: Donatella Tondi
Wydane: (2021-02-01)

Phagosomal granulocytic ROS in septic patients induce the bacterial SOS response
od: Stecy Chollet, i wsp.
Wydane: (2024-06-01)

New Molecular Targets for Antidepressant Drugs
od: Johannes Kornhuber, i wsp.
Wydane: (2021-09-01)

Anthraquinones as Inhibitors of SOS RAS-GEF Activity
od: Alberto Fernández-Medarde, i wsp.
Wydane: (2021-07-01)

After 30 years of study, the bacterial SOS response still surprises us.
Wydane: (2005-07-01)

After 30 years of study, the bacterial SOS response still surprises us.
od: Bénédicte Michel
Wydane: (2005-07-01)

Synthesis, Physicochemical Properties and Molecular Docking of New Benzothiazole Derivatives as Antimicrobial Agents Targeting DHPS Enzyme
od: Rasha A. Azzam, i wsp.
Wydane: (2022-12-01)

Molecular Mechanisms of Glucocorticoid Resistance in Corticotropinomas: New Developments and Drug Targets
od: Denis Ciato, i wsp.
Wydane: (2020-01-01)

Bacterial SOS May Be the Key to Combating Antibiotic Resistance.
Wydane: (2005-06-01)

Focal Targeting of the Bacterial Envelope by Antimicrobial Peptides
od: Rafi eRashid, i wsp.
Wydane: (2016-06-01)

Nano-MOFs as targeted drug delivery agents to combat antibiotic-resistant bacterial infections
od: Saleh A. Ahmed, i wsp.
Wydane: (2020-12-01)

Antibiotic drugs targeting bacterial RNAs
od: Weiling Hong, i wsp.
Wydane: (2014-08-01)

Molecular targets to develop future antimicrobials
od: Mohammed Z. Al-Khayyat
Wydane: (2019-06-01)

Targeting of PBP1 by β-lactams determines recA/SOS response activation in heterogeneous MRSA clinical strains.
od: Konrad B Plata, i wsp.
Wydane: (2013-01-01)

New Insight into the Molecular Drug Target of Diabetic Nephropathy
od: Vivian Soetikno, i wsp.
Wydane: (2014-01-01)

Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents
od: Gail M Wilkes
Wydane: (2018-01-01)

Metabolic network analysis-based identification of antimicrobial drug targets in category A bioterrorism agents.
od: Yong-Yeol Ahn, i wsp.
Wydane: (2014-01-01)

Bacterial Protein Tyrosine Phosphatases as Possible Targets for Antimicrobial Therapies in Response to Antibiotic Resistance
od: Alicja Kuban-Jankowska, i wsp.
Wydane: (2022-12-01)

Targeted Contrast Agents for Molecular MRI
od: Sara Lacerda
Wydane: (2018-12-01)

Design of Photosensitizing Agents for Targeted Antimicrobial Photodynamic Therapy
od: Maxime Klausen, i wsp.
Wydane: (2020-11-01)

Recent Advances in Histidine Kinase-Targeted Antimicrobial Agents
od: Hongtong Chen, i wsp.
Wydane: (2022-07-01)

SOS Mulher
od: Maria das Dores Campos Machado
Wydane: (1999-12-01)

Bacterial Resistance to Antimicrobial Agents
od: Manuel F. Varela, i wsp.
Wydane: (2021-05-01)

Drug-Clinical Agent Molecular Hybrid: Synthesis of Diaryl(trifluoromethyl)pyrazoles as Tubulin Targeting Anticancer Agents
od: Neha Hura, i wsp.
Wydane: (2018-02-01)

New drug target identification in Vibrio vulnificus by subtractive genome analysis and their inhibitors through molecular docking and molecular dynamics simulations
od: Bader S. Alotaibi, i wsp.
Wydane: (2023-07-01)

YY1 downregulation underlies therapeutic response to molecular targeted agents
od: Shichao Zhou, i wsp.
Wydane: (2024-11-01)

Molecular-Targeted Drugs in Rheumatology
od: Eiichi Tanaka
Wydane: (2023-12-01)

Stochastic analysis of the SOS response in Escherichia coli.
od: Yishai Shimoni, i wsp.
Wydane: (2009-01-01)

Novel antimony-based antimicrobial drug targets membranes of Gram-positive and Gram-negative bacterial pathogens
od: Tarosha Salpadoru, i wsp.
Wydane: (2024-06-01)

Editorial: The molecular mechanisms and potential drug targets for remyelination and neuroregeneration
od: Aleksandra Rutkowska, i wsp.
Wydane: (2023-11-01)

Prospective virtual screening combined with bio-molecular simulation enabled identification of new inhibitors for the KRAS drug target
od: Amar Ajmal, i wsp.
Wydane: (2024-03-01)

Toxin Gene Expression by Shiga Toxin-Producing Escherichia coli: the Role of Antibiotics and the Bacterial SOS Response
od: Patrick T. Kimmitt, i wsp.
Wydane: (2000-10-01)

Biology before the SOS Response—DNA Damage Mechanisms at Chromosome Fragile Sites
od: Devon M. Fitzgerald, i wsp.
Wydane: (2021-09-01)

Diarylureas: Repositioning from Antitumor to Antimicrobials or Multi-Target Agents against New Pandemics
od: Alessia Catalano, i wsp.
Wydane: (2021-01-01)

Bacterial signal transduction : networks and drug targets /
od: Utsumi, Ryutaro
Wydane: (2008)